|
|
||||||||
The Annals of Thoracic Surgery, Vol 41, 119-125, Copyright © 1986 by The Society of Thoracic Surgeons
SJ Phillips, RH Zeff, JR Skinner, RS Toon, A Grignon and C Kongtahworn
Reperfusion is an accepted therapy for evolving myocardial infarction (MI),
as successful reperfusion reduces morbidity and mortality. A team approach
between the cardiologists and cardiac surgeons must be applied to achieve
reperfusion within a finite time from the onset of coronary thrombosis.
Analysis of 738 patients grouped them by successful reperfusion in the
catheterization laboratory versus the operating room. Factors that predict
wall motion recovery related to the onset of clinical symptoms, time to
reperfusion, coronary anatomy, and collateral network were reviewed.
Comparisons were made between patients with stable versus unstable
hemodynamics and successful or unsuccessful reperfusion. Of the 738
patients, the initial attempt at reperfusion was made in the
catheterization laboratory with success in 331. These patients all had
primarily single-vessel disease. With multiple-vessel disease identified at
catheterization, 189 patients were immediately treated by surgical
reperfusion. This method also was used for an additional 72 patients in
whom reperfusion could not be achieved in the catheterization laboratory.
Of the entire group of 738 patients, 146 (20%) could not be reperfused.
Overall mortality for the 592 patients reperfused was 4.9% compared with
17% for those who could not be reperfused. Time was critical for wall
motion recovery if no collaterals were demonstrated on angiography. If
collaterals were present, time to reperfusion was not critical. Wall motion
recovered in 90% of the patients if the endocardial anatomy on the initial
angiogram was smooth. However, if the endocardial anatomy looked mottled
and irregular, less than 10% of patients had recovery of wall
motion.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Reperfusion protocol and results in 738 patients with evolving myocardial infarction
This article has been cited by other articles:
![]() |
I. George and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction Card. Surg. Adult, January 1, 2008; 3(2008): 669 - 696. [Full Text] |
||||
![]() |
D. C. Lee, W. Ting, and M. C. Oz Myocardial Revascularization after Acute Myocardial Infarction Card. Surg. Adult, January 1, 2003; 2(2003): 639 - 658. [Full Text] |
||||
![]() |
J. S. Hochman, C. E. Buller, L. A. Sleeper, J. Boland, V. Dzavik, T. A. Sanborn, E. Godfrey, H. D. White, J. Lim, T. LeJemtel, et al. Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry J. Am. Coll. Cardiol., September 1, 2000; 36(3_Suppl_A): 1063 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Sanborn, L. A. Sleeper, E. R. Bates, A. K. Jacobs, J. Boland, J. K. French, J. Dens, V. Dzavik, S. T. Palmeri, J. G. Webb, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry J. Am. Coll. Cardiol., September 1, 2000; 36(3_Suppl_A): 1123 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
S G Williams, D J Wright, and L B Tan Management of cardiogenic shock complicating acute myocardial infarction: towards evidence based medical practice Heart, June 1, 2000; 83(6): 621 - 626. [Full Text] |
||||
![]() |
B. Tomasco, A. Cappiello, R. Fiorilli, A. Leccese, R. Lupino, A. Romiti, and U. F. Tesler Surgical Revascularization for Acute Coronary Insufficiency: Analysis of Risk Factors for Hospital Mortality Ann. Thorac. Surg., September 1, 1997; 64(3): 678 - 683. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |